real-time news and commentary for investors
Wednesday, Aug 14
Tonix Pharmaceuticals closes it public offering
- Tonix Pharmaceuticals Holding (TNXP -2.3%) slips after announcing the closing of its 2.6M share public offering of $4.25 per unit, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
- The company expects to use net proceeds from this offering to fund the clinical development of TNX-102 SL, for which a Phase 2b/3 clinical trial for the treatment of fibromyalgia is in process to begin in the Q313.